Results 101 to 110 of about 7,522 (217)

Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer

Bladder Cancer, 2018
Background: Guidelines recommend a single postoperative instillation of intravesical chemotherapy within 24 hours of transurethral resection of bladder tumors (TURBT) in patients with low- and intermediate-risk non-muscle invasive bladder cancer (NMIBC ...
Lawrence Karsh, Neal Shore, Mark Soloway, Gajanan Bhat, Guru Reddy, Szu-Yun Leu, J. Alfred Witjes   +6 more
doaj   +1 more source

Percentage of Foxp3⁺CD3⁺ T cells in TURBT specimens.

, 2018
(A) Comparison of median (interquartile range) of the percentage of Foxp3+ cells among CD3+ cells in 14 non-bladder cancer controls and 115 TURBT specimens of NMIBC (P + cells in CD3+ cells in three risk groups (P < 0.001, Kruskal-Wallis test).
Akinori Wada (5798282), Kazuo Teramoto (5798276), Mitsuhiro Narita (5319509), Hirohito Ishigaki (322482), Ryosuke Murai (5319497), Akihiro Kawauchi (3438416), Kazumasa Ogasawara (322500), Masayuki Nagasawa (59543), Tetsuya Yoshida (524550), Yasushi Itoh (322471), Shigehisa Kubota (5319503), Susumu Kageyama (3438413), Ken-ichi Kobayashi (5798279), Misako Nakayama (322477), Keiji Tomita (5319506)   +14 more
core   +1 more source

Checklist for Transurethral Resection of Bladder Tumor (TURBT): A Step Forward in the Standardization for TURBT Reporting

European Urology Open Science, 2023
openaire   +4 more sources

Comparison of Presence of Detrusor Muscle in Pathology Between Monopolar Conventional TURBT and En-Bloc TURBT

Journal of North Khorasan University of Medical Sciences, 2020
Koosha Kamali, Pejman Shadpour, Ehsan Zolfi, Vahid Vahedi, Hossein Saffari, Nasrollah Abian   +5 more
openaire   +1 more source

Recurrence-free survival (RFS) rates after TURBT for NMIBC in patients with low (< 17.98%) and high (≥ 17.98%) percentages of Foxp3⁺ cells among CD3⁺ cells by sub-groups according to risk stratification and adjuvant intravesical treatment.

, 2018
(A) RFS rates after TURBT for low-risk NMIBC patients without adjuvant intravesical treatment. Black line: patients with low Foxp3+ cells (n = 21). Red line: patients with high Foxp3+ cells (n = 10). P = 0.220, log-rank test.
Akinori Wada (5798282), Kazuo Teramoto (5798276), Mitsuhiro Narita (5319509), Hirohito Ishigaki (322482), Ryosuke Murai (5319497), Akihiro Kawauchi (3438416), Kazumasa Ogasawara (322500), Masayuki Nagasawa (59543), Tetsuya Yoshida (524550), Yasushi Itoh (322471), Shigehisa Kubota (5319503), Susumu Kageyama (3438413), Ken-ichi Kobayashi (5798279), Misako Nakayama (322477), Keiji Tomita (5319506)   +14 more
core   +1 more source

Comparison of dosimetry between TOMO and VMAT after TURBT for bladder cancer [PDF]

, 2020
Objective To analyze and compare the dosimetric difference between helical tomotherapy (TOMO) and volumetric modulated arc therapy (VMAT) in postoperative patients with bladder cancer, so to provide a reference for optimal radiotherapy technique for ...
LI Hong-ming, YU Lang, LI Rui, SHEN Jie, ZHANG Fu-quan, WU Song
core  

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review

BJUI Compass
Introduction Bladder cancer (BCa) is characterised by high prevalence, multifocality, and frequent recurrence, imposing significant clinical and economic burdens.
Hugo Klempfner, Paul Anderson
doaj   +1 more source

Comparison Between Endoscopic and Percutaneous Approach of Obturator Nerve Block in Case of Transurethral Resection of Bladder Tumour (TURBT)

Background: Bladder cancer is the second most common malignancy of the genitourinary tract. During transurethral resection of bladder tumour (TURBT), stimulation of the obturator nerve, particularly in tumours located on the lateral, posterolateral, or ...
Sudip Das Gupta, Md Abdus Salam, Mohd Iqbal Kabir, Sharmin Akhter, Hadi Zia Uddin Ahmed   +4 more
core   +1 more source

Monopolar Versus Bipolar Trans-Urethral Resection of Bladder Tumours (TURBT): A single centre, parallel arm randomized controlled trial [PDF]

, 2013
INTRODUCTION: Cancer of the urinary bladder is among the commonest malignancies in the world and has a high mortality rate. The initial management in all cases consists of a complete trans-urethral resection of the bladder tumour (TURBT), with a ...
Vivek, Venkatramani
core  

Derivation and validation of the SLNA score: a tumor size-location-number-apperance model to predict transurethral resection of bladder tumor (TURBT) complexity

BACKGROUND: Transurethral resection of bladder tumor (TURBT) is the core surgical procedure for the diagnosis and treatment of bladder cancer, with significant variations in its surgical complexity that directly affect the difficulty of surgical ...
Xu, Yang, Zhu, Jinpeng, Xu, Chuanliang, Zhang, Hui, Zeng, Shuxiong, Zhang, Zhensheng, Xu, Jinshan, Wang, Maoyu, Sheng, Chaoyang, Zhang, Chen   +9 more
core   +1 more source